17β-雌二醇逆转乳腺癌耐药蛋白介导的多药耐药机制

李文通;周庚寅;宋现让;迟伟玲;魏玲;王兴武;张晓芳

解剖学报 ›› 2007, Vol. 38 ›› Issue (1) : 43-46.

欢迎访问《解剖学报》官方网站!今天是 English
解剖学报 ›› 2007, Vol. 38 ›› Issue (1) : 43-46.
论著

17β-雌二醇逆转乳腺癌耐药蛋白介导的多药耐药机制

  • 李文通1;周庚寅1*;宋现让2;迟伟玲3;魏玲2;王兴武2;张晓芳1
作者信息 +

THE STUDY OF THE MECHANISM OF 17βESTRADIOL ON REVERSAL OF THE BREAST CANCER RESISTANT PROTEIN-MEDIATED MULTIDRUG RESISTANCE

Author information +
文章历史 +

Abstract

Objective To explore the mechanism of the reversal of breast cancer resistant protein-mediated multidrug resistance by 17βestradiol. Methods Two BCRP expressing cell lines of MCF-7/MX20 and MCF-7/BCRP were established in which breast canrcer resistant protein(BCRP) was promoted by BCRP promoter and cytomegalovirus(CMV) promoter respectively.These drug resistant cell lines were cultured in medium containing 17βestradiol. Fourtyeight hours later,cytotoxicity assay,mitoxantrone efflux assays,quantitative RT-PCR were performed to observe the reversal function of BCRP by 17βestradiol on MCF-7/MX20 and MCF-7/BCRP respectively. Results After being treated with 17βestradiol,the intensity of mitoxantrone in MCF-7/BCRP was weaker than that in MCF-7/MX20 and the BCRP mRNA level in MCF-7/BCRP was high than that in MCF-7/MX20.The results of these experiments revealed that 17βestradiol could reverse the BCRP mediated multidrug resistance(MDR) in MCF-7/M

关键词

雌激素 / 乳腺癌耐药蛋白 / 基因调控 / 启动子 / 耐药逆转

Key words

Estrogen / Breast cancer resistant protein / Gene regulation / Promoter

引用本文

导出引用
李文通;周庚寅;宋现让;迟伟玲;魏玲;王兴武;张晓芳. 17β-雌二醇逆转乳腺癌耐药蛋白介导的多药耐药机制[J]. 解剖学报. 2007, 38(1): 43-46
THE STUDY OF THE MECHANISM OF 17βESTRADIOL ON REVERSAL OF THE BREAST CANCER RESISTANT PROTEIN-MEDIATED MULTIDRUG RESISTANCE[J]. Acta Anatomica Sinica. 2007, 38(1): 43-46
中图分类号: R966   

Accesses

Citation

Detail

段落导航
相关文章

/